Koninklijke Ahold Delhaize N.V. (ADRNY)

Oncternal Therapeutics Revenue

Koninklijke Ahold Delhaize had revenue of 23.09B EUR in the quarter ending June 29, 2025, with 3.32% growth. This brings the company's revenue in the last twelve months to 91.65B, up 2.88% year-over-year. In the year 2024, Koninklijke Ahold Delhaize had annual revenue of 89.36B with 0.70% growth.

• Revenue (ttm): 91.65B EUR
• Revenue Growth: +2.88%
• P/S Ratio: 0.34
• Revenue / Employee: 236.20K EUR
• Employees: 388,000
• Market Cap: 36.60B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 29, 2024	89.36B	622.00M	0.70%
Dec 31, 2023	88.73B	1.75B	2.01%
Jan 1, 2023	86.98B	11.38B	15.06%
Jan 2, 2022	75.60B	865.00M	1.16%
Jan 3, 2021	74.74B	8.48B	12.79%